capecitabine has been researched along with Cancer of Nasopharynx in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 16 (55.17) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Liu, Y; Liu, Z | 1 |
| Chen, QY; Guo, SS; Liu, LT; Mai, HQ; Sun, XS; Tang, LQ; Zhu, MY | 1 |
| Chua, MLK; Lee, AWM; Ng, WT | 1 |
| Bei, WX; Cai, ZC; Chen, X; Guo, X; Ke, LR; Li, WZ; Liang, CX; Liang, H; Liu, GY; Lu, N; Lv, SH; Lv, X; Wang, DS; Xia, WX; Xiang, YQ; Ye, YF; Zhao, C | 1 |
| Ayyoub, S; Sultan, I | 1 |
| Killock, D | 1 |
| Cao, KJ; Chen, MY; Chen, QY; Chen, ZJ; Guo, L; Guo, X; Hu, D; Hua, YJ; Huang, PY; Ke, LR; Li, WZ; Liang, H; Liu, GY; Liu, T; Lu, N; Luo, DH; Lv, SH; Lv, X; Mai, HQ; Mo, HY; Qian, CN; Qiu, F; Sun, R; Tang, LQ; Tang, WB; Tong, LH; Wang, DS; Wang, L; Xia, WX; Xiang, YQ; Yang, W; Ye, YF; Yuan, TZ; Zhang, HX; Zhao, C | 1 |
| Li, WZ; Liu, GY; Xiang, YQ | 1 |
| Ganguly, S; Gogia, A | 1 |
| Pramanik, R; S G, N; Sharma, A | 1 |
| Bossi, P; Chan, AT; Even, C; Machiels, JP | 1 |
| Chen, N; Han, J; He, J; Lan, X; Shen, X; Tian, K | 1 |
| Cai, XY; Chen, QY; Chen, ZB; Fang, WF; Hu, PL; Hu, WH; Li, XY; Li, YJ; Li, ZM; Lin, MZ; Liu, ZG; Mai, HQ; Peng, JY; Tang, LQ; Wang, XC; Xia, LP; Yang, YP; Yu, QW; Zhang, B; Zhao, C; Zhou, H; Zhou, J | 1 |
| Huo, B; Lin, L; Yang, J; Yu, R; Zhao, L | 1 |
| Chen, QY; Li, XY; Liang, YJ; Liu, SL; Mai, HQ; Sun, XS; Tang, LQ | 1 |
| Chen, L; Chen, YP; Feng, HX; Guo, R; Guo, Y; Hu, GQ; Hu, WH; Huang, J; Jin, F; Li, L; Li, WF; Lin, Q; Liu, X; Liu, ZZ; Luo, XL; Lv, JW; Ma, J; Mao, YP; Mei, Q; Shen, LF; Shi, M; Shi, YX; Sun, R; Sun, Y; Tang, LL; Tian, Y; Wang, H; Wang, XC; Wu, H; Wu, HF; Wu, SG; Xie, FY; Xu, C; Xu, J; Yang, KY; Yue, D; Zang, J; Zhang, N; Zhang, Y; Zheng, BM; Zhou, GQ; Zhou, Q; Zhu, XD | 1 |
| Chen, ZB; Liao, H; Lin, Z; Ou, XQ; Peng, PJ; Peng, YL; Wang, SY; Zhang, HY | 1 |
| Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Wang, XX | 1 |
| Chan, AT; Chan, LL; Chan, OS; Chappell, R; Cheng, A; Cheung, FY; Choi, H; Kwong, DL; Lee, AW; Lu, TX; Ng, WT; Ngan, RK; Tung, SY; Wong, F; Yau, S; Yiu, H; Yuen, KT | 1 |
| Kwong, D; Lam, KO; Lee, V; Leung, TW | 1 |
| Choo, SP; Tan, EH; Wong, M | 1 |
| Chen, SZ; Chen, XM; Ding, Y; Mo, KL; Wang, XC; Zhang, F | 1 |
| Chua, DT; Hong, RL; Krishnan, G; Kurnianda, J; Ng, AW; Ng, WT; Seetalarom, K; Shotelersuk, K; Sze, WK; Wang, CH; Yang, MH; Yiu, HH | 1 |
| Jiang, X; Wang, YX; Yan, D; Yan, S; Yang, J | 1 |
| Au, GK; Chua, DT; Sham, JS | 1 |
| Cao, KJ; Chen, QY; Deng, MQ; Guo, L; Hong, MH; Huang, PY; Jiang, Y; Luo, DH; Mai, HQ; Mo, HY; Qiu, F; Sun, R | 1 |
| Guo, L; Guo, X; Hong, MH; Li, FY; Li, Q; Lin, HX; Luo, DH; Qiu, F | 1 |
| Chen, Y; Deng, YM; He, YJ; Hu, GQ; Jiang, WQ; Li, YH; Lin, Q; Wang, FH; Xiang, XJ; Xu, DM | 1 |
| Au, GK; Chua, D; Sham, JS; Wei, WI | 1 |
12 trial(s) available for capecitabine and Cancer of Nasopharynx
| Article | Year |
|---|---|
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Rand
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Progression-Free Survival | 2022 |
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cisplatin; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel | 2022 |
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
Topics: Capecitabine; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prospective Studies | 2023 |
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Topics: Administration, Metronomic; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Young Adult | 2021 |
Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Endpoint Determination; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organoplatinum Compounds; Survival Analysis; Treatment Failure | 2013 |
Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA, Viral; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2014 |
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fr
Topics: Adult; Aged; Capecitabine; Carcinoma; Chemoradiotherapy, Adjuvant; Deoxycytidine; Dose Fractionation, Radiation; Fluorouracil; Humans; Induction Chemotherapy; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Quality of Life; Survival Analysis; Treatment Outcome; Young Adult | 2012 |
A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Capecitabine; Cisplatin; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate | 2003 |
[Phase I clinical trial evaluation of capecitabine in concurrent combination of radiotherapy in nasopharyngeal carcinoma].
Topics: Adult; Aged; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy Dosage | 2004 |
[Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma].
Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Stomatitis; Thrombocytopenia | 2004 |
Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis | 2008 |
17 other study(ies) available for capecitabine and Cancer of Nasopharynx
| Article | Year |
|---|---|
Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cisplatin; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prognosis; Quality of Life | 2021 |
Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine?
Topics: Capecitabine; Chemoradiotherapy; Humans; Maintenance Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Retrospective Studies | 2021 |
Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box?
Topics: Antimetabolites, Antineoplastic; Capecitabine; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2022 |
Long-term survival in a patient with recurrent nasopharyngeal carcinoma treated with capecitabine.
Topics: Capecitabine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local | 2022 |
Maintenance capecitabine is beneficial in NPC.
Topics: Capecitabine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Progression-Free Survival | 2022 |
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma-Reply.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2022 |
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2022 |
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2022 |
ESMO-EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease.
Topics: Capecitabine; Combined Modality Therapy; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2023 |
Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2022 |
First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Capecitabine; Epistaxis; Humans; Kidney Diseases; Lung Diseases; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Oxaliplatin; Peroxidase; Trastuzumab | 2023 |
The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Propensity Score; Retrospective Studies; Survival Rate; Young Adult | 2020 |
Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Carcinoma; Female; Humans; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiodermatitis | 2016 |
Travel warning with capecitabine.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Dermatoglyphics; Emigration and Immigration; Fingers; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Skin; Travel; United States | 2009 |
Combined chemotherapy with cisplatin, docetaxel and capecitabine for metastatic nasopharyngeal carcinoma: a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Retrospective Studies; Taxoids | 2011 |
Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab treatment for lung metastases in a liver transplantation recipient: a case experience of sustained complete response.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Carcinoma, Hepatocellular; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2012 |
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Odds Ratio; Palliative Care; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2008 |